Conditions We Treat
Alzheimer's disease is a progressive neurological disorder that causes cognitive decline and memory loss. It is the most common form of dementia, accounting for approximately 60-80% of dementia cases. Alzheimer's disease typically affects older adults, although it can also occur in younger individuals.
Treatment for Alzheimer's disease aims to slow the progression of cognitive decline, manage symptoms, and improve quality of life:
Medication Management
Medications such as cholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine) and memantine may be prescribed to improve cognitive function, manage behavioral symptoms, and delay disease progression.
Lifestyle Interventions
Healthy lifestyle habits such as regular exercise, balanced diet, cognitive stimulation, social engagement, and adequate sleep may help improve overall well-being and slow cognitive decline.
Supportive Care
Supportive interventions such as memory aids, safety modifications, assistance with activities of daily living, and caregiver support can help individuals with Alzheimer's disease maintain independence and quality of life.
Clinical Trials
Participation in clinical trials of experimental treatments or interventions may offer opportunities to access new therapies and contribute to research efforts to develop effective treatments for Alzheimer's disease.
In conclusion, Alzheimer's disease is a progressive neurological disorder characterized by cognitive decline, memory loss, and changes in behavior and personality.